BID and cancer: Similarly, research by Jelinek and Wang also found that knocking out the BID gene or using BID inhibitors could protect cells (including normal cells and a variety of cancer cells) from RSL3- or Quercetin-induced cell death by preventing mitochondrial damage (38, 39).